The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives

Glycoconjugate Journal

Volumn 25, Issue 6, 2008, Pages 573-579

  Gómez, José Manuel ^a,b,d   Vila, Ramon ^a   Catalina, Pablo ^c   Soler, Juan ^a,b   Badimón, Lina ^c   Sahún, Manel ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d NONE   (Spain)

Author keywords

C reactive protein; Diabetes mellitus; Endothelial dysfunction; Glycated haemoglobin; Soluble intercellular cell adhesion molecule 1; Soluble vascular cell adhesion molecule 1

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; TRINITRATE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BIOENERGY; BODY COMPOSITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DOPPLER ECHOGRAPHY; ENDOTHELIUM LESION; FEMALE; HUMAN; IMPEDANCE; INFLAMMATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RELATIVE;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; HEMODYNAMICS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 46649092931     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-008-9118-8     Document Type: Article

References (43)

1. Yeh, E.T.H.: CRP as mediator of disease. Circulation 109(suppl II), II-11-II-14 (2004)
2. Meigs, J.B., Hu, F.B., Rifai, N., Mansons, J.A.E.: Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291, 1978-1986 (2004)
3. Temelkova-Kurktschiev, T., Siegert, G., Bergmann, S., Henkel, E., Koehler, C., Jarob, W., Hanefeld, M.: Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 51, 743-749 (2002)
4. Henareh, L., Jogestrand, T., Agewall, S.: Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart disease. Diabet. Med. 22, 1212-1217 (2005)
5. Nakanishi, N., Shiraishi, T., Wada, M.: Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern. Med. 44, 542-547 (2005)
6. Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P.: Endothelial dysfunction, inflammation and diabetes. Rev. Endocr. Metab. Disord. 5, 189-196 (2004)
7. Takeuchi, N., Kawamura, T., Kanai, A., Nakamura, N., Uno, T., Hara, T., Sano, T., Sakamoto, N., Hamada, Y., Nakamura, J., Hotta, N.: The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with type 2 diabetes mellitus. Diabet. Med. 19, 57-64 (2002)
8. Piemonti, L., Calori, G., Mercalli, A., Lattuada, G., Monti, P., Garancini, M.P., Constantino, F., Ruotolo, G., Luzi, L., Perseghin, G.: Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 26, 2883-2889 (2003)
9. Boulbou, M.S., Koukoulis, G.N., Vasiou, K.G., Petinaki, E.A., Gourgoulianis, K.I., Fezoulidis, I.B.: Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease. Int. Angiol. 23, 18-24 (2004)
10. Elhadd, T.A., Kennedy, G., Robb, R., McLaren, M., Jung, R.T., Belch, J.J.F.: Elevated soluble cell adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease. Int. Angiol. 23, 128-133 (2004)
11. Gokulakrishnan, K., Deepa, R., Mohan, D.R., Gross, M.D.: Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome-the Chennai Urban Rural Epidemiology Study. Metabolism 55, 237-242 (2006)
12. Boulbou, M.S., Koukoulis, G.N., Makri, E.D., Petinaki, E.A., Gourgoulianis, K.I., Germenis, A.E.: Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int. J. Cardiol. 98, 39-44 (2005)
13. Vallejo, S., Angulo, J., Peiró, C., Nevado, J., Sánchez-Ferrer, A., Petidier, R., Sánchez-Ferrer, C.F., Rodríguez-Mañas, L.: Highly glycated oxyhaemoglobin impairs oxide relaxation in human mesenteric microvessels. Diabetologia 43, 83-90 (2000)
14. Celermajer, D.S., Sorensen, K.E., Gooch, V.M., Spiegelhalter, D.J., Miller, O.I., Sullivan, I.D., Lloyd, J.K., Deanfield, J.E.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340, 111-1115 (1992)
15. Gómez, J.M., Sahún, M., Vila, R., Domenèch, P., Catalina, P., Soler, J., Badimón, L.: Elevation of E-selectin concentrations may correlate with potential endothelial dysfunction in individuals with hypopituitarism during therapy with growth hormone. Curr. Neurovasc. Res. 4, 55-62 (2007)
16. Landmesser, U., Hornig, B., Drexler, H.: Endothelial function: a critical determinant in atherosclerosis? Circulation 109(21 suppl II), II-27-II-33 (2004)
17. Enderle, M.D., Benda, N., Schmuelling, R.M., Haering, H.U., Pfohl, M.: Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care 21, 271-277 (1998)
18. Balletshofer, B.M., Rittig, K., Enderle, M.D., Volk, A., Maerker, E., Jacob, S., Matthaei, S., Rett, K., Haring, H.U.: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101, 1780-1784 (2000)
19. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C.: Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985)
20. Fernández Castañer, M., Biarnés, J., Camps, I., Ripollés, J., Gómez, N., Soler, J.: Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabet. Med. 13, 953-959 (1999)
21. Fernández Castañer, M., Camps, I., Fernández-Real, J.M., Domenèch, P., Martínez-Brotons, F.: Increased prothrombin fragment 1+2 and D-dimer in first degree relatives of type 2 diabetic patients. Acta Diabetol. 33, 118-121 (1996)
22. Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M.: Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993)
23. Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D., O'Reilly, D.S., Packard, C.J., Sattar, N.: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51, 1596-1600 (2002)
24. Greenfield, J.R., Samaras, K., Jenkins, A.B., Kelly, P.J., Spector, T.D., Gallimore, J.R., Pepys, M.B., Campbell, L.V.: Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109, 3022-3028 (2004)
25. Antoniades, C., Tousoulis, D., Tountas, C., Tentolouris, C., Toutouza, M., Vasiliadou, C., Tsioufis, C., Toutouzas, P., Stefanadis, C.: Vascular endothelium and inflammatory process: in patients with combined type 2 diabetes mellitus and coronary atherosclerosis, the effects of vitamin C. Diabet. Med. 21, 552-558 (2004)
26. Carey, A.L., Bruce, C.R., Sacchetti, M., Anderson, M.J., Olsen, D.B., Saltin, B., Hawley, J.A., Febbraio, M.A.: Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. Diabetologia 47, 1029-1037 (2004)
27. Blann, A.D., Lip, G.Y.H.: Editorial: cell adhesion molecules in cardiovascular disease and its risk factors-what can soluble levels tell us? J. Clin. Endocrinol. Metab. 85, 1745-1747 (2000)
28. Sartipy, P., Loskutoff, D.J.: Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 100, 7265-7270 (2003)
29. McEleavy, O.D., McCallum, R.W., Petrie, J.R., Small, M., Connell, J.M., Sattar, N., Cleland, S.J.: Higher carotid-radial pulse wave velocity in healthy offspring of patients with type 2 diabetes. Diabet. Med. 21, 262-266 (2004)
30. Ostergard, T., Nyholm, B., Hansen, T.K., Rasmussen, L.M., Ingerslev, J., Sorensen, K.E., Botker, H.E., Saltin, B., Schmitz, O.: Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients, the effect of exercise training. Metabolism 55, 1508-1515 (2006)
31. Glowinska, B., Urban, M., Peczynska, J., Florys, B.: Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54, 1020-1026 (2005)
32. Cominacini, L., Fratta Pasini, A., Garbin, U., Davoli, A., De Santis, A., Campagnola, M., Rigoni, A., Zenti, M.G., Moghetti, P., Lo Cascio, V.: Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38, 1122-1124 (1995)
33. Yudkin, J.S., Panahloo, A., Stehouwer, C., Emeis, J.J., Bulmer, K., Mohamed-Ali, V., Denver, A.E.: The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in type II diabetic subjects. Diabetologia 43, 1099-1106 (2000)
34. Stehouwer, C.D.A., Gall, M.A., Twisk, J.W.R., Knudsen, E., Emeis, J.J., Parving, H.H.: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Progressive, interrelated, and independently associated with risk of death. Diabetes 51, 1157-1165 (2002)
35. Empen, K., Frost, R.J.A., Geiss, H.C., Otto, C., Parhofer, K.G.: Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial. Cardiovasc. Diabetol. 2, 17 (2003)
36. Hetzel, J., Balletshofer, B., Rittig, K., Walcher, D., Kratzer, W., Hombach, V., Häring, H.U., Koenig, W., Marx, N.: Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler. Thromb. Vasc. Biol. 25, 1804-1809 (2005)
37. De Jager, J., Kooy, A., Lehert, P.H., Bets, D., Wulffelé, M.G., Teerlink, T., Scheffer, P.G., Schalkwijk, C.G., Donker, A.J.M., Stehouwer, C.D.A.: Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J. Int. Med. 257, 100-109 (2005)
38. Nomura, S., Shouzu, A., Omoto, S., Nishikawa, M., Fukuhara, S., Iwasaka, T.: Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. Thromb. Res. 117, 385-392 (2006)
39. Goodfellow, J., Ramsey, M.W., Luddington, L.A., Jones, C.J., Coates, P.A., Dunstan, F., Lewis, M.J., Owens, D.R., Henderson, A.H.: Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ 312, 744-745 (1996)
40. Avogadro, A., Piarulli, F., Valerio, A.: Forearm nitric oxide balance vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes 46, 1040-1046 (1997)
41. Mäkimattila, S., Liu, M.L., Vakkilainen, J., Schlenzka, A., Lahdenpera, S., Syvanne, M., Mantysaari, M., Summanen, P., Bergholm, R., Taskinen, M.R., Yki-Jarvinen, H.: Impaired endothelium-dependent vasodilatation in type 2 diabetes: relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 22, 973-981 (1999)
42. Natali, A., Toschi, E., Baldeweg, S., Casolaro, A., Baldi, S., Sironi, A.M., Yudkin, J.S., Ferranini, E.: Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur. Heart J. 26, 464-471 (2005)
43. Papaioannou, G.I., Seip, R.L., Grey, N.J., Katten, D., Taylor, A., Inzucchi, S.E., Young, L.H., Chyun, D.A., Davey, J.A., Wackers, F.J.T.H., Iskandrian, A.E., Ratner, R.E., Robinson, E.C., Carolan, S., Engel, S., Heller, G.V.: Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the detection of ischemia in asymptomatic diabetics-brachial artery reactivity study). Am. J. Cardiol. 94, 294-299 (2004)